[SCHEDULE 13G] China SXT Pharmaceuticals, Inc. SEC Filing

Rhea-AI Filing Summary

Singapore investor Ching Choon Hwa has filed a Schedule 13G disclosing passive ownership of 9,803,920 Class A ordinary shares of China SXT Pharmaceuticals (SXTC). The position represents 8.45 % of the company’s 116.0 million total votes outstanding as of 29 Jul 2025. The filing indicates sole voting and dispositive power over the entire stake, with no shared control and no group affiliation. The investor certifies the shares were not acquired to influence control of the issuer. Because the threshold for a 13G filing is 5 %, this disclosure makes Ching Choon Hwa one of SXTC’s largest known individual shareholders, signaling added liquidity and a potential vote bloc but no stated activist intent. No financial performance data, purchase price, or acquisition timeline is provided.

Insights

Financial Analyst

TL;DR: 8.45 % passive stake revealed, adds a sizeable long-only holder; limited immediate valuation impact.

The disclosure elevates SXTC’s free-float visibility, showing a single investor controls nearly one-tenth of voting power. While passive, the position could aid future capital raises or provide a counterweight to insiders. Lack of purchase cost or accumulation pace limits insight into valuation views. Given SXTC’s micro-cap status, any block approaching 10 % can affect liquidity and proxy outcomes, but absent activist language the near-term impact on share price is likely muted.

Corporate Governance Expert

TL;DR: Filing identifies new significant shareholder; governance implications minor because filer disclaims control ambitions.

Ownership concentration shifts modestly. With sole voting power, the investor could influence ordinary resolutions if aligned with other holders, yet remains below 10 % regulatory triggers. The Schedule 13G (vs. 13D) choice confirms a passive stance, reducing governance risk for management. Continuous monitoring is advisable, as conversion to a 13D would signal strategic intent.

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

China SXT Pharmaceuticals, Inc.

(Name of Issuer)

Ordinary shares, $0.51 per Ordinary Share and associated Warrants

(Title of Class of Securities)

G2161P157

(CUSIP Number)

07/29/2025

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

SCHEDULE 13G

CUSIP No. G2161P157

1

Names of Reporting Persons

CHING CHOON HWA

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

SINGAPORE

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 9,803,920.00
6	Shared Voting Power 0.00
7	Sole Dispositive Power 9,803,920.00
8	Shared Dispositive Power 0.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

9,803,920.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

8.45 %

12

Type of Reporting Person (See Instructions)

IN

Comment for Type of Reporting Person: Percentage of class is calculated based on 116,027,758 Ordinary Shares outstanding as of July 29, 2025, which information was provided by the Issuer to the Reporting Person on July 29, 2025. Given that as of July 29, 2025, the Issuer has 116,027,758 Ordinary Shares outstanding, comprising 116,027,226 Class A Ordinary Shares, each entitled to one vote, and 532 Class B Ordinary Shares, each entitled to fifty votes, the total voting power of the Issuer is 116,053,826 votes. The Reporting Person holds 9,803,920 Class A Ordinary Shares, representing approximately 8.45% of the total voting power of the Issuer.

SCHEDULE 13G

Item 1.
(a)	Name of issuer: China SXT Pharmaceuticals, Inc.
(b)	Address of issuer's principal executive offices: 178 TAIDONG ROAD NORTH, TAIZHOU F4 225300
Item 2.
(a)	Name of person filing: CHING CHOON HWA
(b)	Address or principal business office or, if none, residence: Blk 695 Jurong West Central 1 #09-41 Singapore 640695
(c)	Citizenship: SINGAPORE/U0
(d)	Title of class of securities: Ordinary shares, $0.51 per Ordinary Share and associated Warrants
(e)	CUSIP No.: G2161P157
Item 3.	If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)	Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)	Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)	Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)	Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)	An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)	An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)	A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)	A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)	A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)	A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:
(k)	Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.	Ownership
(a)	Amount beneficially owned: 9,803,920
(b)	Percent of class: 8.45%
(c)	Number of shares as to which the person has:
	(i) Sole power to vote or to direct the vote: 9,803,920
	(ii) Shared power to vote or to direct the vote: 0
	(iii) Sole power to dispose or to direct the disposition of: 9,803,920
	(iv) Shared power to dispose or to direct the disposition of: 0
Item 5.	Ownership of 5 Percent or Less of a Class.
	Ownership of 5 percent or less of a class
Item 6.	Ownership of more than 5 Percent on Behalf of Another Person.
	Not Applicable
Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
	Not Applicable
Item 8.	Identification and Classification of Members of the Group.
	Not Applicable
Item 9.	Notice of Dissolution of Group.
	Not Applicable

Item 10.

Certifications:

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

CHING CHOON HWA

Signature:	/s/ CHING CHOON HWA
Name/Title:	CHING CHOON HWA
Date:	08/07/2025